Olympus Biotech offering CMO services for biologics; Almac expands U.K. packaging capacity;

> The FDA has recalled an undisclosed number of lots of the steroid methylprednisolone acetate produced by an undisclosed compounding pharmacy because it is linked to a meningitis outbreak that has infected 14, killing two of them. Story

> Contract services company Almac says it has expanded the packaging capacity at its facility in the U.K. with a new blister packaging line. Release

> Alere says it has worked out with the FDA manufacturing issues for the manufacture of its blood-testing meters for testing heart attacks and will work to bring production up to demand. Story

> Sanofi announced Tuesday that it is buying Genfar, which it termed the second-largest generics maker in Colombia. Story

> Olympus Biotech has begun offering contract manufacturing offering (CMO) at its biologics facility in Lebanon, NH. Release

> A U.S. Senate bill that would impose criminal penalties on companies found price-gouging drugs that are on shortage lists has moved to a committee for consideration. Item

And Finally... Spanish API maker Medichem is letting the world know that its API plant in Girona has passed an FDA inspection for the fifth time in a row and didn't get any 483 write-ups. Release

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.